Drug Shortage Report for TEVA-BUDESONIDE

Last updated on 2025-05-02 History
Report ID 195478
Drug Identification Number 02465957
Brand name TEVA-BUDESONIDE
Common or Proper name TEVA-BUDESONIDE
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) BUDESONIDE
Strength(s) 0.5MG
Dosage form(s) SUSPENSION
Route of administration INHALATION INHALATION
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 20
ATC code R03BA
ATC description OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2023-06-19
Estimated end date 2025-09-30
Actual end date
Shortage status Actual shortage
Updated date 2025-05-02
Company comments Product is under allocation
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v46 2025-01-15 French Compare
v45 2025-01-15 English Compare
v44 2025-01-15 English Compare
v43 2024-11-21 French Compare
v42 2024-11-21 English Compare
v41 2024-11-14 French Compare
v40 2024-11-14 English Compare
v39 2024-11-01 French Compare
v38 2024-11-01 English Compare
v37 2024-10-11 French Compare
v36 2024-10-11 English Compare
v35 2024-09-19 French Compare
v34 2024-09-19 English Compare
v33 2024-07-26 French Compare
v32 2024-07-26 English Compare
v31 2024-07-11 French Compare
v30 2024-07-11 English Compare
v29 2024-05-16 French Compare
v28 2024-05-16 English Compare
v27 2024-05-09 French Compare

Showing 21 to 40 of 66